Published in Chem Biol on September 01, 1997
Structural and mechanistic analysis of protein interactions in module 3 of the 6-deoxyerythronolide B synthase. Chem Biol (2007) 2.02
Polyketide double bond biosynthesis. Mechanistic analysis of the dehydratase-containing module 2 of the picromycin/methymycin polyketide synthase. J Am Chem Soc (2005) 1.33
Active-site residue, domain and module swaps in modular polyketide synthases. J Ind Microbiol Biotechnol (2003) 1.24
ASMPKS: an analysis system for modular polyketide synthases. BMC Bioinformatics (2007) 1.08
Microbial polyketide synthases: more and more prolific. Proc Natl Acad Sci U S A (1999) 1.01
Architectures of whole-module and bimodular proteins from the 6-deoxyerythronolide B synthase. J Mol Biol (2014) 0.98
Analysis of genes involved in biosynthesis of coronafacic acid, the polyketide component of the phytotoxin coronatine. J Bacteriol (1998) 0.92
Quantification of N-acetylcysteamine activated methylmalonate incorporation into polyketide biosynthesis. Beilstein J Org Chem (2013) 0.76
Protein-Protein Interactions, Not Substrate Recognition, Dominate the Turnover of Chimeric Assembly Line Polyketide Synthases. J Biol Chem (2016) 0.75
Genomic expression programs in the response of yeast cells to environmental changes. Mol Biol Cell (2000) 36.09
A new enzyme superfamily - the phosphopantetheinyl transferases. Chem Biol (1996) 4.71
Biosynthesis of complex polyketides in a metabolically engineered strain of E. coli. Science (2001) 4.24
Information access. Building a "GenBank" of the published literature. Science (2001) 3.95
Harnessing the biosynthetic code: combinations, permutations, and mutations. Science (1998) 3.87
Engineered biosynthesis of novel polyketides. Science (1993) 3.16
Precursor-directed biosynthesis of erythromycin analogs by an engineered polyketide synthase. Science (1997) 2.69
Rational design of aromatic polyketide natural products by recombinant assembly of enzymatic subunits. Nature (1995) 2.56
Dissecting and exploiting intermodular communication in polyketide synthases. Science (1999) 2.32
Preparation and characterization of chitosan microparticles intended for controlled drug delivery. Int J Pharm (2002) 2.10
Cloning and heterologous expression of the epothilone gene cluster. Science (2000) 2.06
Role of linkers in communication between protein modules. Curr Opin Chem Biol (2000) 1.94
Crystal structure of the macrocycle-forming thioesterase domain of the erythromycin polyketide synthase: versatility from a unique substrate channel. Proc Natl Acad Sci U S A (2001) 1.80
Assessing the balance between protein-protein interactions and enzyme-substrate interactions in the channeling of intermediates between polyketide synthase modules. J Am Chem Soc (2001) 1.75
Transglutaminase 2 inhibitor, KCC009, disrupts fibronectin assembly in the extracellular matrix and sensitizes orthotopic glioblastomas to chemotherapy. Oncogene (2006) 1.70
Biosynthesis of polyketides in heterologous hosts. Microbiol Mol Biol Rev (2001) 1.55
HbA1c variability is associated with microalbuminuria development in type 2 diabetes: a 7-year prospective cohort study. Diabetologia (2012) 1.54
Engineered biosynthesis of novel polyketides: influence of a downstream enzyme on the catalytic specificity of a minimal aromatic polyketide synthase. Proc Natl Acad Sci U S A (1994) 1.54
IL-17 stimulates the proliferation and differentiation of human mesenchymal stem cells: implications for bone remodeling. Cell Death Differ (2009) 1.53
Preparation of alginate beads for floating drug delivery system: effects of CO(2) gas-forming agents. Int J Pharm (2002) 1.52
Engineered biosynthesis of a complete macrolactone in a heterologous host. Science (1994) 1.52
Mechanism and specificity of the terminal thioesterase domain from the erythromycin polyketide synthase. Chem Biol (1999) 1.51
Selective protein-protein interactions direct channeling of intermediates between polyketide synthase modules. Biochemistry (2001) 1.46
Preparation and characterization of drug-loaded polymethacrylate microspheres by an emulsion solvent evaporation method. J Microencapsul (2003) 1.44
New class of polymers for the delivery of macromolecular therapeutics. Bioconjug Chem (2000) 1.43
Autoimmune cholangitis with features of autoimmune hepatitis: successful treatment with immunosuppressive agents and ursodeoxycholic acid. J Gastroenterol Hepatol (2000) 1.40
Effects of soil pH, temperature and water content on the growth of Burkholderia pseudomallei. Folia Microbiol (Praha) (2003) 1.36
Understanding and exploiting the mechanistic basis for selectivity of polyketide inhibitors of F(0)F(1)-ATPase. Proc Natl Acad Sci U S A (2000) 1.29
Purification and in vitro reconstitution of the essential protein components of an aromatic polyketide synthase. Biochemistry (1998) 1.28
A giant pyogenic granuloma in the nasal cavity caused by nasal packing. Eur Arch Otorhinolaryngol (2002) 1.22
Cloning, nucleotide sequence, and heterologous expression of the biosynthetic gene cluster for R1128, a non-steroidal estrogen receptor antagonist. Insights into an unusual priming mechanism. J Biol Chem (2000) 1.22
Quality and effect of single dose versus split dose of polyethylene glycol bowel preparation for early-morning colonoscopy. Endoscopy (2007) 1.20
Yeast ARS function and nuclear matrix association coincide in a short sequence from the human HPRT locus. Mol Gen Genet (1988) 1.20
Dissecting the role of acyltransferase domains of modular polyketide synthases in the choice and stereochemical fate of extender units. Biochemistry (1999) 1.20
Engineered biosynthesis of novel polyketides: evidence for temporal, but not regiospecific, control of cyclization of an aromatic polyketide precursor. Chem Biol (1994) 1.19
Protein-losing enteropathy: diagnosis with (99m)Tc-labeled human serum albumin scintigraphy. Radiology (2001) 1.19
Molecular cloning and sequence analysis of the complestatin biosynthetic gene cluster. Proc Natl Acad Sci U S A (2001) 1.18
Prolyl endopeptidases. Cell Mol Life Sci (2007) 1.18
Novel therapies for coeliac disease. J Intern Med (2011) 1.17
Apoptolidin, a selective cytotoxic agent, is an inhibitor of F0F1-ATPase. Chem Biol (2001) 1.16
Hepatitis B virus infection in Asian Americans. Gastroenterol Clin North Am (1994) 1.16
Prognostic value of plasma endotoxin levels in patients with cirrhosis. Scand J Gastroenterol (1997) 1.14
Preliminary identification of watershed management strategies for the Houjing river in Taiwan. Water Sci Technol (2010) 1.13
The prescriptions frequencies and patterns of Chinese herbal medicine for allergic rhinitis in Taiwan. Allergy (2006) 1.13
Evidence for two catalytically independent clusters of active sites in a functional modular polyketide synthase. Biochemistry (1996) 1.10
The loading module of rifamycin synthetase is an adenylation-thiolation didomain with substrate tolerance for substituted benzoates. Biochemistry (2001) 1.09
Isolation and characterization of the epothilone biosynthetic gene cluster from Sorangium cellulosum. Gene (2000) 1.08
Spider angiomas in patients with liver cirrhosis: role of alcoholism and impaired liver function. Scand J Gastroenterol (1999) 1.08
Intermodular communication in polyketide synthases: comparing the role of protein-protein interactions to those in other multidomain proteins. Biochemistry (2001) 1.05
Heterologous expression, purification, reconstitution and kinetic analysis of an extended type II polyketide synthase. Chem Biol (1999) 1.05
Tuberculosis in maintenance dialysis patients. Nephron (2001) 1.05
Serum levels of cytokines in hepatitis C-related liver disease: a longitudinal study. Zhonghua Yi Xue Za Zhi (Taipei) (1999) 1.04
Isolation of an ammonium or methylammonium ion transport mutant of Escherichia coli and complementation by the cloned gene. J Bacteriol (1989) 1.04
Paraneoplastic syndromes in patients with hepatocellular carcinoma in Taiwan. Cancer (1999) 1.01
Structure-activity relationships within a family of selectively cytotoxic macrolide natural products. Org Lett (2001) 1.01
Enhancing the atom economy of polyketide biosynthetic processes through metabolic engineering. Biotechnol Prog (2001) 1.01
The effect of ciprofloxacin in the prevention of bacterial infection in patients with cirrhosis after upper gastrointestinal bleeding. Am J Gastroenterol (1998) 1.01
In vitro reconstitution and analysis of the chain initiating enzymes of the R1128 polyketide synthase. Biochemistry (2001) 1.00
Concomitant prescription of non-steroidal anti-inflammatory drugs and antacids in the outpatient setting of a medical center in taiwan: a prescription database study. Eur J Clin Pharmacol (2001) 1.00
Cell-free synthesis of polyketides by recombinant erythromycin polyketide synthases. Nature (1995) 0.99
Combinatorial biosynthesis of 'unnatural' natural products: the polyketide example. Chem Biol (1995) 0.99
Expression of a functional fungal polyketide synthase in the bacterium Streptomyces coelicolor A3(2). J Bacteriol (1995) 0.99
Vanilloid receptor VR1 is both presynaptic and postsynaptic in the superficial laminae of the rat dorsal horn. J Comp Neurol (2001) 0.98
Genes for polyketide secondary metabolic pathways in microorganisms and plants. Ciba Found Symp (1992) 0.98
Precursor-directed biosynthesis of 12-ethyl erythromycin. Bioorg Med Chem (1998) 0.97
Characteristics of felodipine-located poly(epsilon-caprolactone) microspheres. J Microencapsul (2005) 0.96
Mechanistic analysis of a type II polyketide synthase. Role of conserved residues in the beta-ketoacyl synthase-chain length factor heterodimer. Biochemistry (2000) 0.96
Application of integrated GIS and multimedia modeling on NPS pollution evaluation. Environ Monit Assess (2008) 0.96
Engineered biosynthesis of novel polyketides: stereochemical course of two reactions catalyzed by a polyketide synthase. Biochemistry (1994) 0.95
Fatal outcome after ingestion of star fruit (Averrhoa carambola) in uremic patients. Am J Kidney Dis (2000) 0.94
Clinical, virologic, and pathologic significance of elevated serum alpha-fetoprotein levels in patients with chronic hepatitis C. J Clin Gastroenterol (2001) 0.94
Human leukocyte antigen (HLA) frequency among patients with nasopharyngeal carcinoma in Taiwan. Anticancer Res (1990) 0.94
Prevalence of gastric ulcer in cirrhotic patients and its relation to portal hypertension. J Gastroenterol Hepatol (1996) 0.94
Controlled delivery of a hydrophilic drug from a biodegradable microsphere system by supercritical anti-solvent precipitation technique. J Microencapsul (2006) 0.94
Antibodies to hepatitis C virus in prospectively followed patients with posttransfusion hepatitis. J Infect Dis (1991) 0.93
Quantitative measurement of serum HCV RNA in patients with chronic hepatitis C: comparison between Amplicor HCV monitor system and branched DNA signal amplification assay. J Clin Lab Anal (1998) 0.93
Gall-bladder wall thickening in patients with liver cirrhosis. J Gastroenterol Hepatol (1997) 0.93
Human mesenchymal stromal cells are mechanosensitive to vibration stimuli. J Dent Res (2012) 0.93
Prevalence and risk factor analysis of GBV-C/HGV infection in prostitutes. J Med Virol (1997) 0.92
Remarkably broad substrate tolerance of malonyl-CoA synthetase, an enzyme capable of intracellular synthesis of polyketide precursors. J Am Chem Soc (2001) 0.92
Evidence for hepatitis C viral infection in patients with primary hepatocellular carcinoma. West J Med (1994) 0.92
Quantitative branched DNA assay and genotyping for hepatitis C virus RNA in Chinese patients with acute and chronic hepatitis C. J Infect Dis (1995) 0.92
Application of a constructed wetland for industrial wastewater treatment: a pilot-scale study. Chemosphere (2006) 0.91
Deciphering the biosynthetic origin of the aglycone of the aureolic acid group of anti-tumor agents. Chem Biol (1996) 0.91
The prevalence of anti-hepatitis C virus among Chinese patients with hepatocellular carcinoma. Cancer (1992) 0.91
Erythromycin biosynthesis. The 4-pro-S hydride of NADPH is utilized for ketoreduction by both module 5 and module 6 of the 6-deoxyerythronolide B synthase. Bioorg Med Chem Lett (2001) 0.91
Functional orientation of the acyltransferase domain in a module of the erythromycin polyketide synthase. Biochemistry (1998) 0.91
Molecular recognition of diketide substrates by a beta-ketoacyl-acyl carrier protein synthase domain within a bimodular polyketide synthase. Chem Biol (1997) 0.91
Domain analysis of the molecular recognition features of aromatic polyketide synthase subunits. J Biol Chem (1997) 0.90
Substrate specificity of the loading didomain of the erythromycin polyketide synthase. Biochemistry (2000) 0.90
A functional chimeric modular polyketide synthase generated via domain replacement. Chem Biol (1996) 0.90
Utilization of enzymatically phosphopantetheinylated acyl carrier proteins and acetyl-acyl carrier proteins by the actinorhodin polyketide synthase. Biochemistry (1997) 0.90
Chitosan microparticle preparation for controlled drug release by response surface methodology. J Microencapsul (2003) 0.90
Budd-Chiari syndrome due to pacemaker-induced thrombosis. J Gastroenterol Hepatol (1995) 0.89
Manifestations of hypercholesterolaemia, hypoglycaemia, erythrocytosis and hypercalcaemia in patients with hepatocellular carcinoma: report of two cases. J Gastroenterol Hepatol (1999) 0.88
The impact of diabetes on economic costs in dialysis patients: experiences in Taiwan. Diabetes Res Clin Pract (2001) 0.88
Factors predictive of liver cirrhosis in patients with chronic hepatitis B: a multivariate analysis in a longitudinal study. Eur J Gastroenterol Hepatol (2000) 0.88
Branched oligomerization of cell-permeable peptides markedly enhances the transduction efficiency of adenovirus into mesenchymal stem cells. Gene Ther (2010) 0.88
Early-onset stroke associated with a mutation in mitofusin 2. Neurology (2008) 0.88
Kinetic analysis of the actinorhodin aromatic polyketide synthase. J Biol Chem (1999) 0.88